Why should you receive treatment at AMC Cancer Institute?
In 2006, AMC established Korea’s first multidisciplinary cancer institute, initiating its comprehensive approach to cancer treatment. A multidisciplinary clinic is a medical service where multiple specialists from diverse departments gather to provide customized treatment for a cancer patient from diagnosis to surgery. At AMC Cancer Institute, specialists in diagnostic, surgical, medical, and radiation oncology collaborate to develop individualized care plans for each patient.
The Institute has 17 sub-centers that are disease-specific and provides customized cancer treatment through its Center for Personalized Cancer Medicine.
Cancer Institute has conducted the largest number of cancer surgeries in Korea and has the highest survival rate.
The AMC Cancer Institute has published the 2024 Outcomes Book to objectively demonstrate the excellence of its cancer treatment and to present new standards that contribute to improving the quality of care.
Following the development of indicators for liver, colorectal, stomach, breast, and lung cancers in 2023, the 2024 edition presents newly developed indicators for bladder, kidney, and prostate cancers, showcasing the AMC Cancer Institute’s world-class capabilities in the filed of urologic oncology.
Building on its extensive data, the AMC Cancer Institute will continue to pursue evidence-based care and realize patient-centered medical value.
In 2024, AMC Cancer Institute reaffirmed its position as Korea’s leading cancer center, delivering care to over one million cancer patients for the fifth consecutive year.
With a specialized treatment system dedicated to improving both clinical outcomes and quality of life, the institute was ranked among the world’s top five cancer hospitals by Newsweek in its ‘World’s Best Specialized Hospitals 2025’ ranking.